Discovery of potent and selective novel small molecule drugs to target estrogen receptor mutants in endocrine-resistant breast cancer

被引:0
|
作者
Devakrishnan, Anil Kumar
Madasu, Chandrashekhar
Fuqua, Suzanne A. W.
Matzuk, Martin M.
Palaniappan, Murugesan
机构
关键词
D O I
10.1158/1538-7445.AM2024-6576
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6576
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer
    Xin, Lilan
    Wang, Chao
    Cheng, Yan
    Wang, Hongli
    Guo, Xinyi
    Deng, Xiaofei
    Deng, Xiangping
    Xie, Baohua
    Hu, Hankun
    Min, Chang
    Dong, Chune
    Zhou, Hai-Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 8913 - 8931
  • [22] New Targets in Endocrine-Resistant Hormone Receptor-Positive Breast Cancer
    Kennedy, Laura C.
    Mayer, Ingrid A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 511 - 521
  • [23] MPS1 as a novel target in endocrine- and palbociclib-resistant estrogen receptor positive breast cancer
    Nikitorowicz-Buniak, Joanna
    Pancholi, Sunil
    Simigdala, Nikiana
    Ribas, Ricardo
    Linardopoulos, Spiros
    Dowsett, Mitch
    Johnston, Stephen
    Martin, Lesley-Ann
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Experimental and clinical studies reveal the PDGF/AbI pathway as a novel therapeutic target in endocrine-resistant breast cancer
    Weigel, Marion T.
    Ghazoui, Zara
    Lykkesfeldt, Anne E.
    Anderson, Helen
    Dunbier, Anita
    Mundhenke, Christoph
    Dowsett, Mitch
    Martin, Lesley-Ann
    CANCER RESEARCH, 2010, 70
  • [25] Discovery of novel, highly potent and selective small molecule farnesoid X receptor (FXR) agonists
    Richter, Hans G. F.
    Benson, Gregory M.
    Bleicher, Konrad H.
    Blum, Denise
    Chaput, Evelyne
    Clemann, Nicole
    Feng, Song
    Gardes, Christophe
    Grether, Uwe
    Hartman, Peter
    Kuhn, Bernd
    Martin, Rainer E.
    Plancher, Jean-Marc
    Rudolph, Markus
    Schuler, Franz
    Taylor, Sven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [26] Design and Synthesis of Basic Selective Estrogen Receptor Degraders for Endocrine Therapy Resistant Breast Cancer
    Lu, Yunlong
    Gutgesell, Lauren M.
    Xiong, Rui
    Zhao, Jiong
    Li, Yangfeng
    Rosales, Carlo I.
    Hollas, Michael
    Shen, Zhengnan
    Gordon-Blake, Jesse
    Dye, Katherine
    Wang, Yueting
    Lee, Sue
    Chen, Hu
    He, Donghong
    Dubrovyskyii, Oleksii
    Zhao, Huiping
    Huang, Fei
    Lasek, Amy W.
    Tonetti, Debra A.
    Thatcher, Gregory R. J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (24) : 11301 - 11323
  • [27] Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells
    Sarvilinna, N
    Eronen, H
    Miettinen, S
    Vienonen, A
    Ylikomi, T
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (04) : 832 - 840
  • [28] Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells
    Chan, J. Y.
    LaPara, K.
    Yee, D.
    ONCOGENE, 2016, 35 (32) : 4235 - 4243
  • [29] Structure-guided identification of novel dual-targeting estrogen receptor α degraders with aromatase inhibitory activity for the treatment of endocrine-resistant breast cancer
    Xin, Lilan
    Min, Jian
    Hu, Hebing
    Li, Yuanyuan
    Du, Chuanqian
    Xie, Baohua
    Cheng, Yan
    Deng, Xiaofei
    Deng, Xiangping
    Shen, Kang
    Huang, Jian
    Chen, Chun -Chi
    Guo, Rey-Ting
    Dong, Chune
    Zhou, Hai -Bing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 253
  • [30] FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer
    Castillo-Castrejon, Marisol
    Sankofi, Barbara Mensah
    Murguia, Stevi Johnson
    Udeme, Abasi-ama
    Cen, Hoaning Howard
    Xia, Yi Han
    Thomas, Nisha S.
    Berry, William L.
    Jones, Kenneth L.
    Richard, Vincent R.
    Zahedi, Rene P.
    Borchers, Christoph H.
    Johnson, James D.
    Wellberg, Elizabeth A.
    BREAST CANCER RESEARCH, 2023, 25 (01)